Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Pulsed electric field treatment may help shrink untreated liver tumors.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Stem cell vesicles reduced eczema symptoms in mice safely.

Tofacitinib effectively and safely promotes hair regrowth in alopecia patients.

Frontal fibrosing alopecia might be linked to autoimmune diseases.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Dupilumab can help regrow hair in alopecia areata but stopping it may cause hair loss again.

The higher dose supplement was more effective in treating female hair loss.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Farudodstat may help treat alopecia areata by protecting hair follicles.

Dupilumab effectively controls symptoms in infants with Netherton syndrome.

Leflunomide and methotrexate are similarly effective for rheumatoid arthritis but have different side effects.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.

Baricitinib may help treat frontal fibrosing alopecia and facial papules.

Dupilumab for atopic dermatitis can cause mild skin issues in some patients.

Dutasteride may help treat frontal fibrosing alopecia.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Montelukast is linked to increased risks of suicidal thoughts and depression.

Oral tofacitinib is more effective than oral minoxidil for treating alopecia areata.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.